Practique Clinique et Investigation

Home

Practique Clinique et Investigation (DOI prefix: 10.46619) (Clinical Practice & Investigation) from June, 2019 is an International multidisciplinary, peer reviewed scholarly journal that provides an open access platform for the worldwide distribution of original and novel scientific manuscripts/articles based on the various aspects of the adept practical approaches to disease management. The priority of the journal is to publish manuscripts that provide useful insights into the real time efficacy and persisting lacunae in the various principles, tools and techniques involved in the diagnosis and treatment of acute and chronic diseases. The journal serve as a bond between the clinical and medical community and the general society by dispersing scientific advancements in medical and clinical research.

Publishing fees: USD 459
At this stage, the submission and publication of manuscripts is at huge discount (USD 159) for all students/emeritus professor. The published articles are made freely available to online readers.

Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS, http://nihms.nih.gov/).


COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC    https://www.coronavirus.gov
Get the latest research    https://www.who.int/emergencies/diseases/novel-coronavirus-2019


 

Acceptance Rate
75%
Days to process
45
Days to publish
10
Total Articles
35

Recently Published Articles

Review Article | Special Issue | Open Access
Role of Chloroquine and Hydroxychloroquine in the Treatment of COVID-19

Nisreen H Meiqal, Salah M Bensaber, Mousa I Jaeda, Anton Hermann and Abdul M Gbaj

Short Communication | Volume 3, Issue 2 | Open Access
Acute Paraphimosis in Bull and its Surgical Management

Haben Fesseha

Research Article | Volume 3, Issue 2 | Open Access
Pattern of Carotid Plaques in Patients with Transient Ischemic Attack or Ischemic Stroke

Emmanuel Auchi Edafe, Narendra Nath Khanna, Dodo Peter Yakubu, Suparna Rao, Arthur Chukwubike Onwuchekwa

Review Article | Volume 3, Issue 2 | Open Access
Misinterpretation and Misuse of Molecular Biology in the Traceability Issues of Novel Coronavirus

Jin-zhong Gong

Research Article | Volume 3, Issue 2 | Open Access
Treatment Options Being Explored for Corona Virus Infection

Gurmeet Singh Sarla | Kamlesh J. Wadher

Research Article | Volume 3, Issue 2 | Open Access
Evaluation of Implant Time of VVI and DDD Pacemakers in Sub-Saharan Africa Center

Emmmanuel A Edafe

Aims & Scope

Practique Clinique et Investigation (Clinical Practice & Investigation) is dedicated to systematic coverage of the methodology, progress and outcomes of clinical trials, clinical practice and clinical research. As a peer-reviewed, tri-annually publication. It provides a forum for the rapid publication of original research and critically reviews the latest developments in medical research, from Phase 1 trials through to post-marketing studies and pharmaco-economic research.

Each and every year new therapeutic entities enter for clinical use, only one of every 10,000 potential medicines survive the development and approval process. The process of clinical research is highly expensive, involved and complex, with huge demands placed on investigators to deliver robust, reproducible data and to meet the exacting requirements of regulatory authorities.

The scope of the journal:

  • Implementation of complementary therapies (CTs) in the clinical setting
  • Legal and ethical concerns
  • Evaluative accounts of therapy in practice
  • Philosophical analysis of emergent social trends in CTs
  • Excellence in clinical judgement
  • Problem management
  • Therapy information
  • Policy development and management of change in order to promote safe and efficacious clinical practice.
  • Clinical study design and methodology
  • Overviews of the clinical progress of new drugs or drug classes
  • Clinical progress for specific diseases or therapeutic areas
  • Findings in Phase I to IV clinical studies
  • Healthcare outcomes and pharmacoeconomics
  • Patient stratification and individualized therapies
  • Commentary on trials in progress
  • Drug safety issues and adverse event monitoring
  • Biomarkers in clinical trials
  • Regulatory issues
  • Clinical trial data management and statistics